Speech therapy and communication device: Impact on quality of life and mood in patients with amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 1, 2013, Pages 20-25

  Körner, Sonja ^a   Siniawski, Michael ^a   Kollewe, Katja ^a   Rath, Klaus Jan ^a   Krampfl, Klaus ^a   Zapf, Antonia ^a   Dengler, Reinhard ^a,b   Petri, Susanne ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Augmentative and alternative communication; Communication device; Quality of life; Speech therapy

Indexed keywords

ADULT; ALS FUNCTIONAL RATING SCALE REVISED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COMMUNICATION AID; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; DYSARTHRIA; FEMALE; HUMAN; INTERVIEW; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SPEECH THERAPY;

AFFECT; AMYOTROPHIC LATERAL SCLEROSIS; COMMUNICATION AIDS FOR DISABLED; DEPRESSION; DYSARTHRIA; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SPEECH THERAPY; TREATMENT OUTCOME;

EID: 84875434995     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/17482968.2012.692382     Document Type: Article

References (12)

1. Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci. 2010; 294: 81-5.
2. Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS progression. J Neurol Sci. 2008; 275: 69-73.
3. Chio A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy: a 10-year prospective population based study. Neurology. 2009; 72: 725-31.
4. Tomik B, Guiloff RJ. Dysarthria in amyotrophic lateral sclerosis: a review. Amyotroph Lateral Scler. 2010; 11: 4-15.
5. Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, van Damme P, et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2012; 19: 360-75.
6. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess. 1996; 67: 588-97.
7. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473-83.
8. Kuhnlein P, Gdynia HJ, Sperfeld AD, Lindner-Pfl eghar B, Ludolph AC, Prosiegel M, et al. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2008; 4: 366-74.
9. Cohen SM, Elackattu A, Noordzij JP, Walsh MJ, Langmore SE. Palliative treatment of dysphonia and dysarthria. Otolaryngol Clin North Am. 2009; 42: 107-21.
10. Doyle M, Phillips B. Trends in Augmentative and Alternative Communication Use by Individuals with Amyotrophic Lateral Sclerosis. Augmentative and Alternative Communication. 2001; 17: 167-78.
11. Ball LJ, Beukelman DR, Pattee GL. Acceptance of Augmentative and Alternative Communication Technology by Persons with Amyotrophic Lateral Sclerosis. Augmentative and Alternative Communication. 2004; 20: 113-22.
12. Lasker JP, Bedrosian JL. Promoting Acceptance of Augmentative and Alternative Communication by Adults with Acquired Communication Disorders. Augmentative and Alternative Communication. 2001; 17: 141-53.